SCM
GOSS icon

Sio Capital Management’s Gossamer Bio GOSS Stock Holding History

Sio Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-261,400
Closed -$2.12M – 72
2021
Q2 		$2.12M Hold
261,400
– – 0.53% 55
2021
Q1 		$2.42M Buy
+261,400
New +$2.64M 0.49% 61

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sio Capital Management's GOSS Position: Q3 2021 in Review

Sio Capital Management sold out of Gossamer Bio (GOSS) in Q3 2021, closing a stake of 261,400 shares — an estimated $2.12M sold.

Sio Capital Management first reported a position in GOSS in Q1 2021 and held it in 2 quarters. The position peaked at $2.42M in Q1 2021. 127 funds tracked by Wall St. Rank hold GOSS as of Q3 2021.

  • Sio Capital Management reported no remaining Gossamer Bio position as of Q3 2021 after selling out during the quarter.
  • Sio Capital Management sold 261,400 Gossamer Bio shares in Q3 2021, an estimated $2.12M.
  • Sio Capital Management first reported a position in Gossamer Bio in Q1 2021 and held it in 2 quarters.
  • Sio Capital Management's Gossamer Bio position peaked at $2.42M in Q1 2021.
  • 127 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2021.

Based on Sio Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.